Effect of erythropoietin on apoptosis following hyperoxic lung injury in neonatal rats
DING Lu, WU Ben-Qing, HUANG Jin-Jie, LIU Zhi-Ping, CHEN Li
Department of Neonatology, Second Affiliated Hospital of Jinan University/Shenzhen People's Hospital, Shenzhen, Guangdong 518020, China. Email: wubenqing783@126.com
Abstract：OBJECTIVE: To study the effect of recombinant human erythropoietin (rhEPO) on apoptosis following hyperoxic lung injury in neonatal rats. METHODS: Ninety-six neonatal Sprague-Dawley rats were randomly divided into four groups: air-exposed control, air-exposed rhEPO-treated, hyperoxia-exposed placebo (95% oxygen), and hyperoxia-exposed rhEPO-treated. rhEPO (800 U/kg) was administered 2, 4, and 6 days after air or hyperoxia exposure. The rats were sacrificed 3, 7 and 14 days after air or hyperoxia exposure for the assessment of lung histological changes by hematoxylin and eosin staining (n=8 each time point). P-JNK levels were measured by Western blot. Lung cell apoptosis was evaluated by TUNEL assay. RESULTS: Compared with the air-exposed control group, inflammatory cell infiltration was found at 3 days and increased obviously at 7 days, and widening of the alveolar septa was observed, the number of alveoli decreased and normal alveolarization disappeared at 14 days after hyperoxia exposure in the hyperoxia-exposed placebo group. rhEPO treatment alleviated significantly the hyeroxia-induced alterations in lung pathology. P-JNK protein levels and the number of apoptosis cells decreased significantly in the hyperoxia-exposed rhEPO-treated compared with those in the hyperoxia-exposed placebo group. CONCLUSIONS: rhEPO may reduce apoptosis and thus provide a protective effect against hyperoxic lung injury in neonatal rats. JNK signal pathway may be involved in the protective mechanism. ［Chin J Contemp Pediatr, 2010, 12 (7):576-579］
DING Lu,WU Ben-Qing,HUANG Jin-Jie et al. Effect of erythropoietin on apoptosis following hyperoxic lung injury in neonatal rats[J]. CJCP, 2010, 12(07): 576-579.
［1］Cutz E, Chiasson D. Chronic lung disease after premature birth［J］.N Engl J Med, 2008,358(7):743-745.
［2］Thébaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarzation［J］. Circulation,2005,112(16):2477-2486.
［3］Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF. Oxygen toxicity in mouse lung: pathways to cell death［J］.Am J Respir Cell Mo Biol, 1998,19(4):573-581.
［4］McGrath-Morrow SA, Stahl J. Apoptosis in neonatal murine lung exposed to hyperoxia［J］.Am J Respir Cell Mol Biol, 2001,25(2):150 -155.
［5］Usechak P, Gates A, Webster CR. Activation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytes ［J］. J Hepatol, 2008, 49(2): 251-261.
［6］Romashko J 3rd, Horowitz S, Franek WR, Palaia T, Miller EJ, Lin A, et al. MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells ［J］.Free Radic Biol Med, 2003,35(8):978-993.
［7］Morse D, Otterbein LE, Watkins S, Alber S, Zhou Z, Flavell RA, et al. Deficiency in the c-Jun NH2-terminal kinase signaling pathway confers susceptibility to hyperoxic lung injury in mice ［J］.Am J Physiol Lung Cell Mol Physiol, 2003, 285(1):250-257.
［8］Yang G, Abate A, George AG, Weng YH, Dennery PA. Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia ［J］. J Clin Invest, 2004, 114(5):669-678.
［9］Sakashita A, Nishimura Y, Nishiuma T, Takenaka K, Kobayashi K, Kotani Y, et al. Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice［J］.Eur J Pharmacol, 2007, 571(1):62-71.
［10］Liao ZB, Zhi XG, Shi QH, He ZH. Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats ［J］.Eur J Neurol, 2008, 15(2):140-149.
［11］Hochhauser E, Pappo O, Ribakovsky E, Ravid A, Kurtzwald E, Cheporko Y, et al. Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model ［J］. Apoptosis, 2008, 13(1):77-86.
